Skip to main content

Baxter International Value Stock - Dividend - Research Selection

Baxter international

ISIN: US0718131099 , WKN: 853815

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Baxter International Inc. provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. It offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. The company also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors\' offices, and by patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


BDJ: Attractive Monthly Distribution At A Discount

2025-06-29
Discover why BDJ is in the 'buy' zone with its call writing strategy, value-focused portfolio, and reliable monthly distributions.

5 Must-Read Analyst Questions From Baxter’s Q1 Earnings Call

2025-06-26
Baxter’s first quarter saw revenue and adjusted profit both exceed Wall Street expectations, but the market responded cautiously to the results. Management attributed the quarter’s performance to strong execution in Medical Products & Therapies as well as Healthcare Systems & Technologies, highlighting robust demand for infusion systems and progress in stabilizing IV solutions supply after earlier disruptions. Interim CEO Brent Shafer noted, “Our results reflect the building momentum of our stra

Baxter International Inc. stock outperforms competitors on strong trading day

2025-06-24
Baxter International Inc. stock outperforms competitors on strong trading day

Baxter’s infusion pump recalled

2025-06-24
The infusion pump market is set to reach $2.2bn in 2034, according to GlobalData.

Baxter Publishes Annual Corporate Responsibility Report, Demonstrating Ongoing Action to Make a Meaningful Difference Around the World

2025-06-24
DEERFIELD, Ill., June 24, 2025--Baxter International Inc. (NYSE:BAX), a global medtech leader, today published its 2024 Corporate Responsibility Report. The annual report demonstrates Baxter's commitment to transparent reporting and provides updates on the company’s 2030 Corporate Responsibility Commitment and Goals,1 which strive to create a more sustainable and responsible business model.

FMS Stock Likely to Gain on New Optimization Plan FME Reignite

2025-06-24
Fresenius Medical Care unveils FME Reignite, targeting one billion euros in cost savings, tech upgrades and enhanced shareholder returns.

Baxter International : 2024 SASB Index

2025-06-24
Making a Meaningful Difference 2024 Corporate Responsibility Report ...

Medical Devices & Supplies - Diversified Stocks Q1 Teardown: CooperCompanies (NASDAQ:COO) Vs The Rest

2025-06-24
Looking back on medical devices & supplies - diversified stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including CooperCompanies (NASDAQ:COO) and its peers.

Is Baxter International Stock Underperforming the Nasdaq?

2025-06-20
Baxter International has underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.

$16.4 Bn Patient Handling Equipment Markets, 2030 by Patient Transfer (Ceiling Lifts, Stair Lifts, Slings), Medical Beds, Mobility Equipment (Walkers, Canes, Crutches), Stretchers

2025-06-18
The global patient handling equipment market is set to grow from USD 12.4 billion in 2025 to USD 16.4 billion by 2030, at a CAGR of 5.8%. Key growth drivers include the aging population and rising prevalence of cardiovascular diseases, necessitating advanced and ergonomic devices. A surge in home healthcare services across North America, Europe, and Asia Pacific further boosts demand. The patient transfer devices segment, particularly patient lifts, dominates due to increasing awareness and musc